We are live on ! Find out more
UONDDL

University of Notre Dame du Lac Portfolio holdings

AUM $66.8M
1-Year Est. Return 43.52%
This Fund
S&P 500
This Quarter Est. Return
+17.91%
1 Year Est. Return
+43.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$74.8M
AUM Growth
-$22.9M
Cap. Flow
-$36.5M
Cap. Flow %
-48.85%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
1
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$24.1M
2
SYRE icon
Spyre Therapeutics
SYRE
+$12.4M

Sector Composition

Rank Sector Weight
1 Financials 100%
2 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.B icon
1
Berkshire Hathaway Class B
BRK.B
$1.11T
$74.8M 100%
177,781
-61,250
-26% -$24.1M
SYRE icon
2
Spyre Therapeutics
SYRE
$9.06B
– –
-577,616
Closed -$12.4M

Similar funds

PPL
PATRIZIA Pty Ltd Barton, Australia $67.3M AUM 26.18% 1-Year Est. Return
ACH
Avista Capital Holdings New York $68.4M AUM 23% 1-Year Est. Return
TM
Titan Managers Scottsdale, Arizona $63.6M AUM 0.03% 1-Year Est. Return
SVG
Sun Valley Gold Sun Valley, Idaho $63.2M AUM 182.76% 1-Year Est. Return
DLDF
Dan L. Duncan Foundation Houston, Texas $70.6M AUM 22.88% 1-Year Est. Return
AGFIA
Accel Growth Fund IV Associates Palo Alto, California $58.7M AUM 25.19% 1-Year Est. Return
ARC
Arias Resource Capital George Town, Grand Cayman, Cayman Islands $58.6M AUM 26.15% 1-Year Est. Return
ST
SAL Trading Bala Cynwyd, Pennsylvania $57M AUM 33.89% 1-Year Est. Return

University of Notre Dame du Lac's Q1 2024 Portfolio in Review

As of Q1 2024, University of Notre Dame du Lac held 2 positions worth $74.8M, down 23% from $97.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

University of Notre Dame du Lac withdrew a net $36.5M in Q1 2024, closing 1 position and reducing 1 holding. Its most notable exit was Spyre Therapeutics, an estimated $12.4M position sold in full.

By sector, the portfolio is most concentrated in Financials at 100% of assets, up from 87% a quarter earlier, followed by Healthcare.

  • University of Notre Dame du Lac's biggest Q1 2024 reduction was Berkshire Hathaway Class B, cutting an estimated $24.1M.
  • University of Notre Dame du Lac fully exited Spyre Therapeutics in Q1 2024, selling an estimated $12.4M.
  • University of Notre Dame du Lac's ten largest holdings make up 100% of its $74.8M portfolio in Q1 2024.
  • University of Notre Dame du Lac opened 0 new positions and closed 1 in Q1 2024.
  • University of Notre Dame du Lac's portfolio value fell 23% quarter-over-quarter to $74.8M.

Based on University of Notre Dame du Lac's 13F filing for Q1 2024, filed 14 May 2024.